XML 36 R26.htm IDEA: XBRL DOCUMENT v3.25.2
SEGMENT INFORMATION (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below details the Company’s revenues, significant expenses, and other segment items and reconciles those amounts to the Company’s consolidated net loss as computed under U.S. GAAP in the accompanying Condensed Consolidated Statements of Operations:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Revenues$18,306 $356 $24,743 $837 
Less:
Research and development14,643 14,916 29,754 36,082 
General and administrative7,514 8,183 16,782 18,360 
Clinical manufacturing operations11,420 8,301 21,076 20,856 
Impairment of long-lived assets— 1,172 — 5,521 
Stock-based compensation2,226 3,065 4,822 5,784 
Other segment items (*)
2,489 847 2,892 (549)
Net loss$(19,986)$(36,128)$(50,583)$(85,217)
(*) Other segment items include restructuring charges, interest income, other (expense) income, net, and income tax expense.